FMP
NASDAQ
3.14 USD
0.11 (3.5%)
Mr. Talat Imran
Healthcare
Biotechnology
https://www.ranitherapeutics.com
NASDAQ
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatm...
0001856725
US7530181004
753018100
2051 Ringwood Avenue
408 457 3700
US
140
Jul 30, 2021
0001856725
NASDAQ
Biotechnology
Healthcare
753018100
US7530181004
US
3.14
0.97
79.4k
157.49M
-
1.82-5.81
-0.93
-
-
-
-
-2.36
-
https://www.ranitherapeutics.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.